М. В. Козлов

1.3k total citations
39 papers, 1.1k citations indexed

About

М. В. Козлов is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, М. В. Козлов has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Infectious Diseases and 6 papers in Organic Chemistry. Recurrent topics in М. В. Козлов's work include RNA and protein synthesis mechanisms (10 papers), Histone Deacetylase Inhibitors Research (9 papers) and HIV/AIDS drug development and treatment (8 papers). М. В. Козлов is often cited by papers focused on RNA and protein synthesis mechanisms (10 papers), Histone Deacetylase Inhibitors Research (9 papers) and HIV/AIDS drug development and treatment (8 papers). М. В. Козлов collaborates with scholars based in Russia, United States and Germany. М. В. Козлов's co-authors include Arkady Mustaev, Alex Goldfarb, Vadim Nikiforov, Seth A. Darst, Nataliya Korzheva, Arun Malhotra, Vadim Markovtsov, Evgeny Zaychikov, Sergey N. Kochetkov and Vasily Sosunov and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

М. В. Козлов

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by М. В. Козлов

Since Specialization

Citations

This map shows the geographic impact of М. В. Козлов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. В. Козлов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. В. Козлов more than expected).

Fields of papers citing papers by М. В. Козлов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. В. Козлов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. В. Козлов. The network helps show where М. В. Козлов may publish in the future.

Co-authorship network of co-authors of М. В. Козлов

This figure shows the co-authorship network connecting the top 25 collaborators of М. В. Козлов. A scholar is included among the top collaborators of М. В. Козлов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. В. Козлов. М. В. Козлов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis 2025 ·Pharmaceutics ·Pavel Spirin, (unknown), (unknown), А. В. Морозов, (unknown), (unknown), (unknown), Yuri B. Porozov, (unknown), Timofey Lebedev, М. В. Козлов, Vladimir Prassolov	0
2	In-Cell Testing of Zinc-Dependent Histone Deacetylase Inhibitors in the Presence of Class-Selective Fluorogenic Substrates: Potential and Limitations of the Method 2024 ·Biomedicines ·(unknown), (unknown), Sergey N. Kochetkov, М. В. Козлов	1
3	How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication 2023 ·Молекулярная биология ·(unknown), Sergey N. Kochetkov, М. В. Козлов	0
4	Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro 2022 ·Biochimie ·(unknown), М. В. Козлов, (unknown), (unknown), Danil Pupov, Daria Esyunina, Sergey N. Kochetkov, Andrey Kulbachinskiy	6
5	Structural isomers of cinnamic hydroxamic acids block HCV replication via different mechanisms 2019 ·European Journal of Medicinal Chemistry ·М. В. Козлов, (unknown), (unknown), (unknown), (unknown), Pavel N. Solyev, Sergey N. Kochetkov	7
6	Synthesis of Pyridyl-4-Oxy-Substituted N-Hydroxy Amides of Cinnamic Acid as New Inhibitors of Histone Deacetylase Activity and Hepatitis C Virus Replication 2018 ·Russian Journal of Bioorganic Chemistry ·М. В. Козлов, (unknown), (unknown), (unknown), Sergey N. Kochetkov	4
7	Synthesis of (Z)-N-hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication 2016 ·Russian Journal of Bioorganic Chemistry ·М. В. Козлов, (unknown), (unknown), (unknown), (unknown), Роман А. Новиков, Sergey N. Kochetkov	3
8	Pyridine hydroxamic acids are specific anti-HCV agents affecting HDAC6 2015 ·Bioorganic & Medicinal Chemistry Letters ·М. В. Козлов, (unknown), Lyudmila I. Romanova, (unknown), (unknown), Olga A. Smirnova, Vladimir Prassolov, Sergey N. Kochetkov	15
9	Benzohydroxamic acids as potent and selective anti-HCV agents 2013 ·Bioorganic & Medicinal Chemistry Letters ·М. В. Козлов, (unknown), Lyudmila I. Romanova, (unknown), Olga A. Smirnova, (unknown), Sergey N. Kochetkov	19
10	New Cross-Linking Quinoline and Quinolone Derivatives for Sensitive Fluorescent Labeling 2012 ·Journal of Fluorescence ·(unknown), М. В. Козлов, Salvatore A. E. Marras, Lev N. Krasnoperov, Arkady Mustaev	17
11	New cross-linking quinoline and quinolone based luminescent lanthanide probes for sensitive labeling 2012 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·(unknown), (unknown), М. В. Козлов, Salvatore A. E. Marras, Lev N. Krasnoperov, Arkady Mustaev	2
12	RNA-dependent RNA polymerase of hepatitis C virus: Study on inhibition by α,γ-diketo acid derivatives 2009 ·Biochemistry (Moscow) ·М. В. Козлов, K. M. Polyakov, (unknown), (unknown), (unknown), Sergey N. Kochetkov	4
13	Molecular structures of antiviral agents, 2,3-dihydroxybenzaldehyde 2,4-dinitrophenylhydrazone and 4-[(4-methylpiperazin-1-yl)imino]methyl-1,2-benzodiol 2008 ·Crystallography Reports ·(unknown), V. E. Zavodnik, (unknown), М. В. Козлов	2
14	Hepatitis C virus RNA-dependent RNA polymerase: Study on the inhibition mechanism by pyrogallol derivatives 2006 ·Biochemistry (Moscow) ·М. В. Козлов, K. M. Polyakov, Alexander V. Ivanov, (unknown), (unknown), V. L. Tunitskaya, Sergey N. Kochetkov	5
15	Homogeneous fluorescent assay for RNA polymerase 2005 ·Analytical Biochemistry ·М. В. Козлов, Veit Bergendahl, Richard R. Burgess, Alex Goldfarb, Arkady Mustaev	21
16	New Non-nucleoside Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase 2004 ·Biochemistry (Moscow) ·Alexander V. Ivanov, М. В. Козлов, (unknown), (unknown), V. L. Tunitskaya, Sergey N. Kochetkov	5
17	Donation of catalytic residues to RNA polymerase active center by transcription factor Gre 2003 ·Proceedings of the National Academy of Sciences ·(unknown), Vasily Sosunov, М. В. Козлов, Vadim Nikiforov, Alex Goldfarb, Arkady Mustaev	103
18	Strategies and Methods of Cross-Linking of RNA Polymerase Active Center 2003 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), (unknown), M.A. Grachev, М. В. Козлов, Konstantin Severinov, Vitaly Epshtein, Nataliya Korzheva, Oxana Bereshchenko, Vadim Markovtsov, Eugeny A. Lukhtanov, (unknown), (unknown), Mikhail Kashlev, I. A. Bass, Vadim Nikiforov, Alex Goldfarb	9
19	Probing contacts of phosphate groups of oligonucleotides from the non-template strand of lac UV5 promoter with E. coli RNA polymerase using regioselective cross-linking. 2000 ·PubMed ·(unknown), (unknown), М. В. Козлов, (unknown), (unknown), (unknown)	4
20	Mapping of Catalytic Residues in the RNA Polymerase Active Center 1996 ·Science ·Evgeny Zaychikov, Emil Martin, (unknown), М. В. Козлов, Vadim Markovtsov, Mikhail Kashlev, Hermann Heumann, Vadim Nikiforov, Alex Goldfarb, Arkady Mustaev	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact